These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 7521830)

  • 1. Parenteral aminoglycoside therapy. Selection, administration and monitoring.
    Kumana CR; Yuen KY
    Drugs; 1994 Jun; 47(6):902-13. PubMed ID: 7521830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycosides once daily?
    Drug Ther Bull; 1997 May; 35(5):36-7. PubMed ID: 9282419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aminoglycoside-induced nephrotoxicity].
    Fabrizii V; Thalhammer F; Hörl WH
    Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of aminoglycoside therapy: a single daily dose.
    Deamer RL; Dial LK
    Am Fam Physician; 1996 Apr; 53(5):1782-6. PubMed ID: 8623702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria.
    Klastersky J; Thys JP; Mombelli G
    Rev Infect Dis; 1981; 3(1):74-83. PubMed ID: 7013002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycosides--50 years on.
    Begg EJ; Barclay ML
    Br J Clin Pharmacol; 1995 Jun; 39(6):597-603. PubMed ID: 7654476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
    Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic monitoring of amikacin and gentamicin in routine clinical practice].
    Kacířová I; Grundmann M
    Vnitr Lek; 2015 Jan; 61(1):33-41. PubMed ID: 25693614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicologic and pharmacologic considerations in the choice of empiric parenteral antibiotics.
    Glauser MP; Neftel KA
    Am J Med; 1986 May; 80(5C):64-9. PubMed ID: 3717190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity.
    Chan GL
    DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside therapy in infectious diseases.
    Poulikakos P; Falagas ME
    Expert Opin Pharmacother; 2013 Aug; 14(12):1585-97. PubMed ID: 23746121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.